½ÃÀ庸°í¼­
»óǰÄÚµå
1534599

¼¼°èÀÇ ´ëÀå±Õ °Ë»ç ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® - °Ë»çº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° Àü¸Á ¹× ¿¹Ãø(2024-2031³â)

Global E-coli Testing Market Size, Share & Trends Analysis Report By Test (Environmental Test, and Clinical Test), By End User (Diagnostic Laboratories, Hospitals, and Physicians Offices), By Regional Outlook and Forecast, 2024 - 2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: KBV Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 161 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ´ëÀå±Õ °Ë»ç ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ µ¿¾È CAGR 6.3%·Î ¼ºÀåÇÏ¿© 2031³â±îÁö 31¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ ½ÄÀ½·á »ê¾÷ÀÌ ¼ºÀåÇÔ¿¡ µû¶ó ±â¾÷µéÀº Áö¼ÓÀûÀ¸·Î ½ÅÁ¦Ç°À» °³¹ßÇÏ°í µµÀÔÇϰí ÀÖ½À´Ï´Ù. °¢ ½ÅÁ¦Ç°Àº ´ëÀå±Õ ¹× ±âŸ ¿À¿° ¹°ÁúÀÌ Æ÷ÇÔµÇÁö ¾Ê¾Ò´ÂÁö È®ÀÎÇϱâ À§ÇØ ¾ö°ÝÇÑ °Ë»ç¸¦ °ÅÃÄ¾ß ÇÕ´Ï´Ù. ½ÅÁ¦Ç° ¶óÀÎÀÇ ¾ÈÀü¼º¿¡ ´ëÇÑ ÀÌ·¯ÇÑ ¼ö¿ä´Â ´ëÀå±Õ °Ë»ç ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ ¼ºÀåÇÏ´Â ½ÄÀ½·á »ê¾÷ÀÌ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

±×·¯³ª ºÐÀÚÁø´Ü(PCR µî), Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS), ÀÚµ¿È­ ½Ã½ºÅÛ µî ÷´Ü °Ë»ç ±â¼ú¿¡´Â ¸¹Àº ÀÚ±Ý ÅõÀÚ°¡ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. ¿©±â¿¡´Â Àåºñ ±¸¸Å, À¯Áöº¸¼ö ¹× Á¶Á¤, ÀåºñÀÇ È¿°úÀûÀÎ »ç¿ëÀ» À§ÇÑ Àη ±³À°¿¡ µå´Â ºñ¿ëÀÌ Æ÷ÇԵ˴ϴÙ.

°Ë»ç Àü¸Á

°Ë»ç¸¦ ±âÁØÀ¸·Î ½ÃÀåÀº ȯ°æ °Ë»ç¿Í ÀÓ»ó °Ë»ç·Î ³ª´¹´Ï´Ù. ÀÓ»ó °Ë»ç ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 32%ÀÇ ¸ÅÃâ Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù. ¿ä·Î°¨¿°Áõ(UTI), Ç÷·ù°¨¿°Áõ, À§À庴 µî ´ëÀå±Õ °ü·Ã °¨¿°ÁõÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµ Àü¸Á

ÃÖÁ¾»ç¿ëÀÚ¸¦ ±âÁØÀ¸·Î ½ÃÀåÀº º´¿ø, Áø´Ü ½ÇÇè½Ç, Ŭ¸®´ÐÀ¸·Î ³ª´µ¸ç, 2023³â¿¡´Â Áø´Ü ½ÇÇè½Ç ºÎ¹®ÀÌ ½ÃÀå¿¡¼­ 43%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º´¿ø¿¡¼­´Â ´Ù¾çÇÑ º´À» ¾Î°íÀִ ȯÀÚ°¡ ¸¹ÀÌ ¹æ¹®Çϱ⠶§¹®¿¡ ´ëÀå±Õ °¨¿°ÀÌ ¹ß»ýÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

Áö¿ª Àü¸Á

Áö¿ªº°·Î º¸¸é ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ °ÉÃÄ ºÐ¼®µÇ¾úÀ¸¸ç, 2023³â ¾Æ½Ã¾ÆÅÂÆò¾çÀº ½ÃÀå¿¡¼­ 25%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ±Þ¼ÓÇÑ µµ½ÃÈ­¿Í »ê¾÷È­·Î ÀÎÇØ ¼öÀÚ¿øÀÇ ¿À¿°°ú ¿À¿°ÀÌ Áõ°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • ½ÃÀå Á¤ÀÇ
  • ¸ñÀû
  • ½ÃÀå ¹üÀ§
  • ¼¼ºÐÈ­
  • Á¶»ç ¹æ¹ý

Á¦2Àå ½ÃÀå ¿ä¶÷

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®

Á¦3Àå ½ÃÀå °³¿ä

  • ¼Ò°³
    • °³¿ä
      • ½ÃÀå ±¸¼º°ú ½Ã³ª¸®¿À
  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
    • ½ÃÀå °úÁ¦
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ´ëÀå±Õ °Ë»ç ½ÃÀå : °Ë»çº°

  • ¼¼°èÀÇ È¯°æ °Ë»ç ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ÀÓ»ó °Ë»ç ½ÃÀå : Áö¿ªº°

Á¦5Àå ¼¼°èÀÇ ´ëÀå±Õ °Ë»ç ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼¼°èÀÇ Áø´Ü °Ë»ç½Ç ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ º´¿ø ½ÃÀå : Áö¿ªº°
  • ¼¼°èÀÇ ÀÇ»ç ¿ÀÇǽº ½ÃÀå : Áö¿ªº°

Á¦6Àå ¼¼°èÀÇ ´ëÀå±Õ °Ë»ç ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ºÏ¹Ì ½ÃÀå : ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
      • ±âŸ ºÏ¹Ì
  • À¯·´
    • À¯·´ ½ÃÀå : ±¹°¡º°
      • µ¶ÀÏ
      • ¿µ±¹
      • ÇÁ¶û½º
      • ·¯½Ã¾Æ
      • ½ºÆäÀÎ
      • ÀÌÅ»¸®¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå : ±¹°¡º°
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • Çѱ¹
      • ½Ì°¡Æ÷¸£
      • ¸»·¹À̽þÆ
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå : ±¹°¡º°
      • ºê¶óÁú
      • ¾Æ¸£ÇîÆ¼³ª
      • ¾Æ¶ø¿¡¹Ì¸®Æ®
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
      • ³ªÀÌÁö¸®¾Æ
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦7Àå ±â¾÷ °³¿ä

  • Pro Lab Diagnostics Inc
  • NanoLogix, Inc
  • CPI International
  • BioMerieux
  • Thermo Fisher Scientific, Inc
  • Bio-Rad laboratories, Inc
  • Meridian Bioscience, Inc(SD Biosensor Co., Ltd.)
  • Becton, Dickinson, and Company
  • IDEXX Laboratories, Inc

Á¦8Àå ´ëÀå±Õ °Ë»ç ½ÃÀåÀÇ ¼º°ø Çʼö Á¶°Ç

ksm 24.08.21

The Global E-coli Testing Market size is expected to reach $3.1 billion by 2031, rising at a market growth of 6.3% CAGR during the forecast period.

North America has experienced notable outbreaks of food-borne illnesses linked to E-coli contamination in foods like ground beef, leafy greens, and other produce. This has heightened the demand for routine E-coli testing in the food industry to prevent outbreaks and protect public health. The region has a well-developed healthcare infrastructure with numerous hospitals, clinics, and diagnostic laboratories equipped with advanced diagnostic technologies. The high healthcare delivery and diagnostic testing capacity contributes to the significant demand for E-coli testing. Thus, the North America region segment acquired 39% revenue share in the market 2023.

Personalized medicine approaches involve close monitoring and management for individuals with chronic or recurrent E-coli infections. Advanced E-coli testing technologies enable regular and detailed assessment of infection status, allowing for personalized treatment and adjustments to management strategies.

Additionally, companies continuously develop and introduce new products as the food and beverage industry grows. Each new product requires rigorous testing to ensure it is free from E-coli and other contaminants. This demand for safety in new product lines contributes to the growth of the E-coli testing market. Therefore, the growing food and beverage industry is driving growth.

However, advanced testing technologies, such as molecular diagnostics (e.g., PCR), next-generation sequencing (NGS), and automated systems, often require substantial financial investment. This includes costs for purchasing equipment, maintaining and calibrating it, and training personnel to use it effectively.

Test Outlook

Based on the test, the market is divided into environmental test and clinical test. The clinical test segment witnessed 32% revenue share in the market in 2023. E-coli-related infections are increasing, including urinary tract infections (UTIs), bloodstream infections, and gastrointestinal illnesses.

End-Use Outlook

On the basis of end user, the market is segmented into hospitals, diagnostic laboratories, and physicians' offices. In 2023, the diagnostic laboratories segment attained 43% revenue share in the market. Hospitals experience a high volume of patients with diverse medical conditions, increasing the likelihood of encountering E-coli infections.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 25% revenue share in the market. The Asia Pacific region is experiencing rapid urbanization and industrialization, which can lead to increased pollution and contamination of water sources.

List of Key Companies Profiled

  • BIOMERIEUX
  • Bio-Rad Laboratories, Inc.
  • Pro Lab diagnostics
  • NanoLogix, Inc.
  • Thermo Fisher Scientific
  • CPI International
  • Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
  • Becton, Dickinson and Company
  • IDEXX Laboratories, Inc.

Global E-coli Testing Market Report Segmentation

By Test

  • Environmental Test
  • Clinical Test

By End User

  • Diagnostic Laboratories
  • Hospitals
  • Physicians Offices

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global E-coli Testing Market, by Test
    • 1.4.2 Global E-coli Testing Market, by End User
    • 1.4.3 Global E-coli Testing Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. Global E-coli Testing Market by Test

  • 4.1 Global Environmental Test Market by Region
  • 4.2 Global Clinical Test Market by Region

Chapter 5. Global E-coli Testing Market by End User

  • 5.1 Global Diagnostic Laboratories Market by Region
  • 5.2 Global Hospitals Market by Region
  • 5.3 Global Physicians Offices Market by Region

Chapter 6. Global E-coli Testing Market by Region

  • 6.1 North America E-coli Testing Market
    • 6.1.1 North America E-coli Testing Market by Test
      • 6.1.1.1 North America Environmental Test Market by Region
      • 6.1.1.2 North America Clinical Test Market by Region
    • 6.1.2 North America E-coli Testing Market by End User
      • 6.1.2.1 North America Diagnostic Laboratories Market by Country
      • 6.1.2.2 North America Hospitals Market by Country
      • 6.1.2.3 North America Physicians Offices Market by Country
    • 6.1.3 North America E-coli Testing Market by Country
      • 6.1.3.1 US E-coli Testing Market
        • 6.1.3.1.1 US E-coli Testing Market by Test
        • 6.1.3.1.2 US E-coli Testing Market by End User
      • 6.1.3.2 Canada E-coli Testing Market
        • 6.1.3.2.1 Canada E-coli Testing Market by Test
        • 6.1.3.2.2 Canada E-coli Testing Market by End User
      • 6.1.3.3 Mexico E-coli Testing Market
        • 6.1.3.3.1 Mexico E-coli Testing Market by Test
        • 6.1.3.3.2 Mexico E-coli Testing Market by End User
      • 6.1.3.4 Rest of North America E-coli Testing Market
        • 6.1.3.4.1 Rest of North America E-coli Testing Market by Test
        • 6.1.3.4.2 Rest of North America E-coli Testing Market by End User
  • 6.2 Europe E-coli Testing Market
    • 6.2.1 Europe E-coli Testing Market by Test
      • 6.2.1.1 Europe Environmental Test Market by Country
      • 6.2.1.2 Europe Clinical Test Market by Country
    • 6.2.2 Europe E-coli Testing Market by End User
      • 6.2.2.1 Europe Diagnostic Laboratories Market by Country
      • 6.2.2.2 Europe Hospitals Market by Country
      • 6.2.2.3 Europe Physicians Offices Market by Country
    • 6.2.3 Europe E-coli Testing Market by Country
      • 6.2.3.1 Germany E-coli Testing Market
        • 6.2.3.1.1 Germany E-coli Testing Market by Test
        • 6.2.3.1.2 Germany E-coli Testing Market by End User
      • 6.2.3.2 UK E-coli Testing Market
        • 6.2.3.2.1 UK E-coli Testing Market by Test
        • 6.2.3.2.2 UK E-coli Testing Market by End User
      • 6.2.3.3 France E-coli Testing Market
        • 6.2.3.3.1 France E-coli Testing Market by Test
        • 6.2.3.3.2 France E-coli Testing Market by End User
      • 6.2.3.4 Russia E-coli Testing Market
        • 6.2.3.4.1 Russia E-coli Testing Market by Test
        • 6.2.3.4.2 Russia E-coli Testing Market by End User
      • 6.2.3.5 Spain E-coli Testing Market
        • 6.2.3.5.1 Spain E-coli Testing Market by Test
        • 6.2.3.5.2 Spain E-coli Testing Market by End User
      • 6.2.3.6 Italy E-coli Testing Market
        • 6.2.3.6.1 Italy E-coli Testing Market by Test
        • 6.2.3.6.2 Italy E-coli Testing Market by End User
      • 6.2.3.7 Rest of Europe E-coli Testing Market
        • 6.2.3.7.1 Rest of Europe E-coli Testing Market by Test
        • 6.2.3.7.2 Rest of Europe E-coli Testing Market by End User
  • 6.3 Asia Pacific E-coli Testing Market
    • 6.3.1 Asia Pacific E-coli Testing Market by Test
      • 6.3.1.1 Asia Pacific Environmental Test Market by Country
      • 6.3.1.2 Asia Pacific Clinical Test Market by Country
    • 6.3.2 Asia Pacific E-coli Testing Market by End User
      • 6.3.2.1 Asia Pacific Diagnostic Laboratories Market by Country
      • 6.3.2.2 Asia Pacific Hospitals Market by Country
      • 6.3.2.3 Asia Pacific Physicians Offices Market by Country
    • 6.3.3 Asia Pacific E-coli Testing Market by Country
      • 6.3.3.1 China E-coli Testing Market
        • 6.3.3.1.1 China E-coli Testing Market by Test
        • 6.3.3.1.2 China E-coli Testing Market by End User
      • 6.3.3.2 Japan E-coli Testing Market
        • 6.3.3.2.1 Japan E-coli Testing Market by Test
        • 6.3.3.2.2 Japan E-coli Testing Market by End User
      • 6.3.3.3 India E-coli Testing Market
        • 6.3.3.3.1 India E-coli Testing Market by Test
        • 6.3.3.3.2 India E-coli Testing Market by End User
      • 6.3.3.4 South Korea E-coli Testing Market
        • 6.3.3.4.1 South Korea E-coli Testing Market by Test
        • 6.3.3.4.2 South Korea E-coli Testing Market by End User
      • 6.3.3.5 Singapore E-coli Testing Market
        • 6.3.3.5.1 Singapore E-coli Testing Market by Test
        • 6.3.3.5.2 Singapore E-coli Testing Market by End User
      • 6.3.3.6 Malaysia E-coli Testing Market
        • 6.3.3.6.1 Malaysia E-coli Testing Market by Test
        • 6.3.3.6.2 Malaysia E-coli Testing Market by End User
      • 6.3.3.7 Rest of Asia Pacific E-coli Testing Market
        • 6.3.3.7.1 Rest of Asia Pacific E-coli Testing Market by Test
        • 6.3.3.7.2 Rest of Asia Pacific E-coli Testing Market by End User
  • 6.4 LAMEA E-coli Testing Market
    • 6.4.1 LAMEA E-coli Testing Market by Test
      • 6.4.1.1 LAMEA Environmental Test Market by Country
      • 6.4.1.2 LAMEA Clinical Test Market by Country
    • 6.4.2 LAMEA E-coli Testing Market by End User
      • 6.4.2.1 LAMEA Diagnostic Laboratories Market by Country
      • 6.4.2.2 LAMEA Hospitals Market by Country
      • 6.4.2.3 LAMEA Physicians Offices Market by Country
    • 6.4.3 LAMEA E-coli Testing Market by Country
      • 6.4.3.1 Brazil E-coli Testing Market
        • 6.4.3.1.1 Brazil E-coli Testing Market by Test
        • 6.4.3.1.2 Brazil E-coli Testing Market by End User
      • 6.4.3.2 Argentina E-coli Testing Market
        • 6.4.3.2.1 Argentina E-coli Testing Market by Test
        • 6.4.3.2.2 Argentina E-coli Testing Market by End User
      • 6.4.3.3 UAE E-coli Testing Market
        • 6.4.3.3.1 UAE E-coli Testing Market by Test
        • 6.4.3.3.2 UAE E-coli Testing Market by End User
      • 6.4.3.4 Saudi Arabia E-coli Testing Market
        • 6.4.3.4.1 Saudi Arabia E-coli Testing Market by Test
        • 6.4.3.4.2 Saudi Arabia E-coli Testing Market by End User
      • 6.4.3.5 South Africa E-coli Testing Market
        • 6.4.3.5.1 South Africa E-coli Testing Market by Test
        • 6.4.3.5.2 South Africa E-coli Testing Market by End User
      • 6.4.3.6 Nigeria E-coli Testing Market
        • 6.4.3.6.1 Nigeria E-coli Testing Market by Test
        • 6.4.3.6.2 Nigeria E-coli Testing Market by End User
      • 6.4.3.7 Rest of LAMEA E-coli Testing Market
        • 6.4.3.7.1 Rest of LAMEA E-coli Testing Market by Test
        • 6.4.3.7.2 Rest of LAMEA E-coli Testing Market by End User

Chapter 7. Company Profiles

  • 7.1 Pro Lab Diagnostics Inc.
    • 7.1.1 Company Overview
  • 7.2 NanoLogix, Inc.
    • 7.2.1 Company Overview
  • 7.3 CPI International
    • 7.3.1 Company Overview
  • 7.4 BioMerieux
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expenses
    • 7.4.5 SWOT Analysis
  • 7.5 Thermo Fisher Scientific, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expenses
    • 7.5.5 SWOT Analysis
  • 7.6 Bio-Rad laboratories, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expenses
    • 7.6.5 SWOT Analysis
  • 7.7 Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
  • 7.8 Becton, Dickinson, and Company
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 SWOT Analysis
  • 7.9 IDEXX Laboratories, Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 Research & Development Expenses
    • 7.9.5 SWOT Analysis

Chapter 8. Winning Imperatives for E-coli Testing Market

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦